be_ixf;ym_202208 d_17; ct_50

Select Page

Latest Insights on ADGI

erratic biotech stocks This New Strategy Makes Sense of Biotechs’ Erratic Moves I find one type of stock equal parts frustrating and fascinating — biotechs.
ev production supply chain crisis EV Makers Finally Found a Supply Chain Solution Automakers lost control over their supply chains. And they aren’t looking to repeat this mistake with their EV projects.
market moves short-term trading BIG Market Moves Mean BIG Opportunities When the market moves this much, day trading has the potential to be lucrative.
omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.
2022 stock predictions 5 Bold Predictions for 2022 and Beyond These will be the biggest growth themes for 2022.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

“Looks like I have finally found the right person to learn and grow from.”

- James

“Loving this. Should have started a long time ago.”

- Jay

Share This